Cost-Effectiveness Analysis in Comparing Alginate Silver Dressing with Silver Zinc Sulfadiazine Cream in the Treatment of Pressure Ulcers

 

 Permissions and Reprints

Background The treatment of pressure ulcers is complicated, given the various wound dressing products available. The cost of different treatments varies and the cost-effectiveness of each product has not been thoroughly evaluated. We compare two wound dressing protocols-alginate silver dressing (AlSD) and silver zinc sulfadiazine cream (AgZnSD) with regard to wound healing and cost-effectiveness.

Methods Patients with grade III or IV sacral or trochanteric pressure ulcers were eligible for this prospective, randomized controlled trial. The patients were randomized to receive one of the two dressings for an eight-week period. The criteria of efficacy were based on the Pressure Ulcer Scale for Healing (PUSH) scoring tool. The cost of treatment was also assessed.

Results Twenty patients (12 women and 8 men) were randomly assigned to receive either AlSD (n=10) or AgZnSD cream (n=10). The demographic data and wound characteristics were comparable in the two groups. The two groups showed no significant difference in the reduction of PUSH score, wound size, or volume of exudate. The tissue type score was significantly lower in the AlSD group (3.15±0.68-1.85±0.68 vs. 2.73±0.79-2.2±0.41; P=0.015). The cost of treatment was significantly lower in the AlSD group (377.17 vs. 467.74 USD, respectively; P<0.0001).

Conclusions Alginate silver dressing could be effectively used in the treatment of grade III and IV pressure ulcers. It can improve wound tissue characteristics and is cost-effective.

This article was presented as a poster at the European Wound Management Association (EWMA) on May 25-27, 2011 in Brussels, Belgium.

Publication History

Received: 30 January 2013

Accepted: 25 July 2013

Article published online:
01 May 2022

© 2013. The Korean Society of Plastic and Reconstructive Surgeons. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonCommercial License, permitting unrestricted noncommercial use, distribution, and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes. (https://creativecommons.org/licenses/by-nc/4.0/)

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

• References

• 1 Vanderwee K, Clark M, Dealey C. et al. Pressure ulcer prevalence in Europe: a pilot study. J Eval Clin Pract 2007; 13: 227-235
  CrossrefPubMedGoogle Scholar
• 2 Tannen A, Dassen T, Bours G. et al. A comparison of pressure ulcer prevalence: concerted data collection in the Netherlands and Germany. Int J Nurs Stud 2004; 41: 607-612
  CrossrefPubMedGoogle Scholar
• 3 Bennett G, Dealey C, Posnett J. The cost of pressure ulcers in the UK. Age Ageing 2004; 33: 230-235
  CrossrefPubMedGoogle Scholar
• 4 Xakellis GC, Frantz R. The cost of healing pressure ulcers across multiple health care settings. Adv Wound Care 1996; 9: 18-22
  PubMedGoogle Scholar
• 5 Inman KJ, Sibbald WJ, Rutledge FS. et al. Clinical utility and cost-effectiveness of an air suspension bed in the prevention of pressure ulcers. JAMA 1993; 269: 1139-1143
  CrossrefPubMedGoogle Scholar
• 6 Reddy M, Gill SS, Kalkar SR. et al. Treatment of pressure ulcers: a systematic review. JAMA 2008; 300: 2647-2662
  CrossrefPubMedGoogle Scholar
• 7 Mooney EK, Lippitt C, Friedman J. et al. Silver dressings. Plast Reconstr Surg 2006; 117: 666-669
  CrossrefPubMedGoogle Scholar
• 8 Lansdown AB. Silver. I: Its antibacterial properties and mechanism of action. J Wound Care 2002; 11: 125-130
  CrossrefPubMedGoogle Scholar
• 9 Hermans MH. Silver-containing dressings and the need for evidence. Adv Skin Wound Care 2007; 20: 166-173
  CrossrefPubMedGoogle Scholar
• 10 Thomas S, McCubbin P. An in vitro analysis of the antimicrobial properties of 10 silver-containing dressings. J Wound Care 2003; 12: 305-308
  CrossrefPubMedGoogle Scholar
• 11 Hooper SJ, Williams DW, Thomas DW. et al. An in vitro comparison of two silver-containing antimicrobial wound dressings. Ostomy Wound Manage 2012; 58: 16-22
  PubMedGoogle Scholar
• 12 Percival SL, Slone W, Linton S. et al. The antimicrobial efficacy of a silver alginate dressing against a broad spectrum of clinically relevant wound isolates. Int Wound J 2011; 8: 237-243
  CrossrefPubMedGoogle Scholar
• 13 Ricci KE, Pittarello M, Cassino R. et al. AskinaCalgitrol Ag®: clinical use of an advanced ionic silver dressing. Acta Vulnologica 2008; 5: 105-111
  Google Scholar
• 14 Addison D, Rennison TJ, Del Bono M. The antimicrobial properties of a silver alginate dressing for moderate to heavily exuding, wounds: 688. J Wound Ostomy Continence Nurs 2005; 32: S28
  Google Scholar
• 15 Opasanon S, Muangman P, Namviriyachote N. Clinical effectiveness of alginate silver dressing in outpatient management of partial-thickness burns. Int Wound J 2010; 7: 467-471
  CrossrefPubMedGoogle Scholar
• 16 Schulz KF, Altman DG, Moher D. et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c332
  CrossrefPubMedGoogle Scholar
• 17 Black J, Baharestani MM, Cuddigan J. et al. National Pressure Ulcer Advisory Panel's updated pressure ulcer staging system. Adv Skin Wound Care 2007; 20: 269-274
  CrossrefPubMedGoogle Scholar
• 18 Livesley NJ, Chow AW. Infected pressure ulcers in elderly individuals. Clin Infect Dis 2002; 35: 1390-1396
  CrossrefPubMedGoogle Scholar
• 19 Parish LC, Witkowski JA. The infected decubitus ulcer. Int J Dermatol 1989; 28: 643-647
  CrossrefPubMedGoogle Scholar
• 20 Fuller FW. The side effects of silver sulfadiazine. J Burn Care Res 2009; 30: 464-470
  CrossrefPubMedGoogle Scholar
• 21 Stotts NA, Rodeheaver GT, Thomas DR. et al. An instrument to measure healing in pressure ulcers: development and validation of the pressure ulcer scale for healing (PUSH). J Gerontol A Biol Sci Med Sci 2001; 56: M795-M799
  CrossrefPubMedGoogle Scholar